9Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics, 1998, 13:397- 409.
10Lau GK, Piratvisuth T, Luo KX, et al. Peginterferon Alfa2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med, 2005, 352:2682-2695.
7KROGSGGAARD K, BINDSLEV N, CREISTENSEN E, et al. The treatment effect of alpha interferon in chronic hepatitis B is inde- pendent of pretreatmerit variables. European concerted action on Viral Hepatitis [ J ]. J Hepato, 1994,21:646 - 655.